MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-02-28
2025-08-31
2025-05-31
Net income (loss)
-
-31,814
51,395
Depreciation
-
-
3,775
Amortization
-
-
7,251
Impairment expenses
-
-
3,463
Due to related party
-
-3,500
-
Changes in other assets
-
-
50,079
Due to shareholder
-
0
-
Increase in accounts receivable
-
-
-11,500
Interest receivable
-
0
-
Accrued interest
-
0
-436
Accounts receivable
-
0
-
Account payable and accrued expenses
-
3,564
-1,211
Advances from related parties
-
28,250
-31,058
Net cash provided by (used in) operating activities
-
3,500
-4,528
Equipment, net
-
0
-
Intangibles, net
-
0
-
Net cash provided by (used in) investing activities
-
0
0
Additional paid-in capital
-
-3,500
-
Proceeds from sale of common stock
-
-
0
Proceeds from note payable others
-
0
-
Apic
-
-
3,500
Proceeds from note payable related party
-
0
-
Accrued interest
-
0
0
Net cash provided by financing activities
-
-3,500
3,500
Increase (decrease) in cash and equivalents
0
0
-1,028
Cash and equivalents at beginning of the period
0
0
1,028
Cash and equivalents at end of the period
0
0
0
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
No Cash Flow statement diagram available.
Buy us a coffee
Exousia Bio, Inc. (LMMY)
Exousia Bio, Inc. (LMMY)